144 related articles for article (PubMed ID: 26491856)
1. Successful Use of Eltrombopag in a Child With Hurler Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation.
Naithani R; Sachdev M; Uttam R
J Pediatr Hematol Oncol; 2016 Mar; 38(2):163-4. PubMed ID: 26491856
[No Abstract] [Full Text] [Related]
2. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
Fu H; Zhang X; Han T; Mo X; Wang Y; Chen H; Han W; Wang J; Wang F; Yan C; Zhang Y; Sun Y; Liu K; Huang X; Xu L
Bone Marrow Transplant; 2019 Aug; 54(8):1310-1318. PubMed ID: 30664724
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag use in a patient with Wiskott-Aldrich syndrome.
Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
Modi Y; Shaaban H; Gauchan D; Maroules M
J Oncol Pharm Pract; 2015 Feb; 21(1):74-5. PubMed ID: 25063763
[TBL] [Abstract][Full Text] [Related]
6. Comment on: Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
Akyay A; Öncül Y
Pediatr Blood Cancer; 2020 Sep; 67(9):e28304. PubMed ID: 33332023
[No Abstract] [Full Text] [Related]
7. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
Gauchan D; Shaaban H; Gedeon D; Maroules M
Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304
[No Abstract] [Full Text] [Related]
8. Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia.
Fiore M; Saut N; Alessi MC; Viallard JF
Platelets; 2016 Dec; 27(8):828-829. PubMed ID: 27276516
[No Abstract] [Full Text] [Related]
9. [Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation].
Ma YR; Huang XJ; Mo XD; Han W; Yan CH; Chen Y; Ji Y; Chen YY; Wang Y; Zhang XH; Liu KY; Xu LP
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1065-1069. PubMed ID: 28088971
[TBL] [Abstract][Full Text] [Related]
10. Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia.
Trautmann K; Jakob C; von Grünhagen U; Schleyer E; Brümmendorf TH; Siegert G; Ehninger G; Platzbecker U
Thromb Haemost; 2012 Aug; 108(2):397-8. PubMed ID: 22739569
[No Abstract] [Full Text] [Related]
11. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.
Reid R; Bennett JM; Becker M; Chen Y; Milner L; Phillips GL; Liesveld J
Am J Hematol; 2012 Jul; 87(7):743-5. PubMed ID: 22573520
[TBL] [Abstract][Full Text] [Related]
12. Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient.
Duic JP; Grewal J; McConie K; Staszewski H; Haas J; Kesari S
J Neurooncol; 2012 Jan; 106(2):427-9. PubMed ID: 21833801
[No Abstract] [Full Text] [Related]
13. The Successful Sequential Use of Plerixafor and Eltrombopag For Hematopoietic Cell Transplantation in a Child With High-risk Neuroblastoma.
Marjanska A; Czyzewski K; Debski R; Krenska A; Wysocki M; Styczynski J
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e680-e682. PubMed ID: 31306338
[TBL] [Abstract][Full Text] [Related]
14. A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.
Liesveld JL; Phillips GL; Becker M; Constine LS; Friedberg J; Andolina JR; Milner LA; DeBolt J; Smudzin T; Hyrien O; Erickson-Miller CL; Johnson BM; Dawson KL; Chen Y
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1745-52. PubMed ID: 24120380
[TBL] [Abstract][Full Text] [Related]
15. [Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors].
García Lagunar MH; Cerezuela Fuentes P; Martínez Penella M; Gutiérrez-Meca Maestre DP; García Coronel M; Martínez Ortiz MJ
Farm Hosp; 2015 May; 39(3):157-60. PubMed ID: 26005891
[TBL] [Abstract][Full Text] [Related]
16. Eltrombopag in thrombocytopenia.
Lawson A
N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18322290
[No Abstract] [Full Text] [Related]
17. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
[TBL] [Abstract][Full Text] [Related]
18. [Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C: two case reports].
Guglieri-López B; Ventura-Cerdá JM; Carmena-Carmena J; Climente-Mónica M
Farm Hosp; 2013; 37(5):419-21. PubMed ID: 24128106
[No Abstract] [Full Text] [Related]
19. Usage of eltrombopag for chronic immune thrombocytopenia as a pretreatment for splenectomy.
Uwagawa T; Misawa T; Furukawa K; Ito R; Futagawa Y; Yahagi Y; Aiba K; Yanaga K
Acta Haematol; 2013; 129(1):45-7. PubMed ID: 23128016
[No Abstract] [Full Text] [Related]
20. Eltrombopag Therapy in Children With Rare Disorders Associated With Thrombocytopenia.
Frączkiewicz J; Sęga-Pondel D; Kazanowska B; Ussowicz M
J Pediatr Hematol Oncol; 2020 Mar; 42(2):113-117. PubMed ID: 31205222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
